Particle.news
Download on the App Store

Spire Healthcare Launches Strategic Review, Hires Rothschild to Weigh Possible Sale

The move follows pressure from major investors who argue the private hospital group is undervalued.

Overview

  • The board said the process is at a highly preliminary stage and that it has received no approaches or engaged in active sale talks.
  • Shares jumped sharply on the news, closing about 14% higher at 247p after rising as much as 18% intraday.
  • Harwood Capital, holding roughly 5%, and other investors have urged options including a sale, citing an unencumbered property portfolio of about £1.4bn and growth plans in occupational health targeting £40m of annual EBITDA.
  • Spire operates 38 hospitals and more than 50 clinics across the UK, serving both private patients and the NHS.
  • Mediclinic is the largest shareholder at just under 30% with board representation, and investors recall a 250p-per-share bid from Ramsay Health Care that shareholders rejected in 2021.